IRIS

The cerebrospinal fluid (CSF) biomarkers amyloid beta 1-42, total tau, and phosphorylated tau are used increasingly for Alzheimer's disease (AD) research and patient management. However, there are large variations in biomarker measurements among and within laboratories.

Mattsson, N., Andreasson, U., Persson, S., Carrillo, M., Collins, S., Chalbot, S., et al. (2013). CSF biomarker variability in the Alzheimer's Association quality control program. ALZHEIMER'S & DEMENTIA, 9(3), 251-261 [10.1016/j.jalz.2013.01.010].

CSF biomarker variability in the Alzheimer's Association quality control program

SANCESARIO, GIUSEPPE;BERNARDINI, SERGIO;STEFANI, ALESSANDRO;
2013-05-01

Abstract

The cerebrospinal fluid (CSF) biomarkers amyloid beta 1-42, total tau, and phosphorylated tau are used increasingly for Alzheimer's disease (AD) research and patient management. However, there are large variations in biomarker measurements among and within laboratories.
mag-2013
Pubblicato
Rilevanza internazionale
Articolo
Esperti anonimi
Settore BIO/12 - BIOCHIMICA CLINICA E BIOLOGIA MOLECOLARE CLINICA
English
Reproducibility of Results; Humans; Alzheimer Disease; tau Proteins; Laboratories, Hospital; Peptide Fragments; Phosphorylation; Amyloid beta-Peptides; Chemistry, Clinical; Enzyme-Linked Immunosorbent Assay; Quality Control; Societies, Medical; Biological Markers
Mattsson, N., Andreasson, U., Persson, S., Carrillo, M., Collins, S., Chalbot, S., et al. (2013). CSF biomarker variability in the Alzheimer's Association quality control program. ALZHEIMER'S & DEMENTIA, 9(3), 251-261 [10.1016/j.jalz.2013.01.010].
Mattsson, N; Andreasson, U; Persson, S; Carrillo, M; Collins, S; Chalbot, S; Cutler, N; Dufour Rainfray, D; Fagan, A; Heegaard, N; Robin Hsiung, G; Hyman, B; Iqbal, K; Lachno, D; Lleó, A; Lewczuk, P; Molinuevo, J; Parchi, P; Regeniter, A; Rissman, R; Rosenmann, H; Sancesario, G; Schröder, J; Shaw, L; Teunissen, C; Trojanowski, J; Vanderstichele, H; Vandijck, M; Verbeek, M; Zetterberg, H; Blennow, K; Käser, S; Andreasson, U; Persson, S; Arai, H; Batish, S; Bernardini, S; Bocchio Chiavetto, L; Blankenstein, M; Carrillo, M; Chalbot, S; Coart, E; Chiasserini, D; Cutler, N; Dahlfors, G; Duller, S; Fagan, A; Forlenza, O; Frisoni, G; Galasko, D; Galimberti, D; Hampel, H; Handberg, A; Heneka, M; Herskovits, A; Herukka, S; Holtzman, D; Humpel, C; Hyman, B; Iqbal, K; Jukcer, M; Kaeser, S; Kaiser, E; Kapaki, E; Kidd, D; Klivenyi, P; Knudsen, C; Kummer, M; Lui, J; Lladó, A; Lewezuk, P; Li, Q; Martins, R; Masters, C; Mcauliffe, J; Mercken, M; Moghekar, A; Molinuevo, J; Montine, T; Nowatzke, W; O'Brien, R; Otto, M; Paraskevas, G; Parnetti, L; Petersen, R; Prvulovic, D; de Reus, H; Rissman, R; Scarpini, E; Stefani, A; Soininen, H; Schröder, J; Shaw, L; Skinningsrud, A; Skrogstad, B; Spreer, A; Talib, L; Teunissen, C; Trojanowski, J; Tumani, H; Umek, R; Van Broeck, B; Vanderstichele, H; Vecsei, L; Verbeek, M; Windisch, M; Zhang, J; Zetterberg, H; Blennow, K
Articolo su rivista
01 - Articolo su rivista
File in questo prodotto:
File Dimensione Formato  
1-s2.0-S1552526013000423-main (1).pdf

accesso aperto

Descrizione: PDF
Dimensione 1.3 MB
Formato Adobe PDF
Visualizza/Apri
1.3 MB Adobe PDF Visualizza/Apri

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/2108/97350
Citazioni
  • ???jsp.display-item.citation.pmc??? ND
  • Scopus 304
  • ???jsp.display-item.citation.isi??? 288
social impact